Women with cardiovascular disease (CVD) have a substantially higher adiposity-associated risk for breast cancer.

Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms.

Sleep disorders contribute to mental health challenges, traumatic injuries, and increased health care utilization in active-duty service members.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.